Compare Plug Power Inc (PLUG) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Plug Power Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Plug Power Inc trades at $1.75 (market cap $2.49B), while State Street SPDR S&P Biotech ETF trades at $149.65 (market cap $10.08B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 4× Plug Power Inc's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Plug Power Inc for 41 Days and State Street SPDR S&P Biotech ETF for 37 Days on average.
| PLUG | XBI | |
|---|---|---|
Market Cap | $2.49B | $10.08B |
Volume | 47,846,349 | 9,534,635 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $4.14 | $169.55 |
52-Week Low | $1.73 | $104.99 |
Typical Hold Time | 41 Days | 37 Days |
Enterprise Value | $3.36B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Plug Power (PLUG) trades at $1.73, down 6.99% today, with a bearish technical signal and negative earnings momentum. The company continues to report significant losses with a -220.59% net income margin and negative cash flow, though recent electrolyzer supply agreements and international expansion provide some operational catalysts. Analyst sentiment is mixed with 44.73% buy ratings but a consensus price target of $3.13 suggesting 81% upside potential from current levels.
The stock faces substantial fundamental challenges with persistent losses and negative cash flow, but maintains analyst support due to its positioning in the growing green hydrogen market. Key risks include execution challenges in achieving profitability, high cash burn requiring continued financing, and competitive pressures in the clean energy sector. The current price near the analyst low target of $1.65 indicates limited downside protection.
XBI trades at $150.23, down 0.44% on the day, with bearish technical signals dominating. The ETF faces resistance near $152-154 while finding support at $147-149 levels. Analyst coverage remains limited with a single hold rating, though recent news highlights biotech sector optimism from M&A activity and cancer vaccine breakthroughs. The fund's 0.35% expense ratio compares unfavorably to broader healthcare ETFs but offers targeted biotech exposure.
Outlook remains mixed with technical weakness offset by sector catalysts. The biotech focus provides growth potential but carries higher volatility than diversified healthcare alternatives. Key risks include sector-specific regulatory pressures and the fund's expense structure, while opportunities exist from ongoing pharmaceutical innovation and capital market improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
